AzTrials
AzTrials

Memory, EpisodicSAMENCT05847933

Influence of Temporo-occipital Transcranial Magnetic Brain Stimulation on Aversive Episodic Memory Performance

A study testing rTMS (cTBS 50Hz experiment), rTMS (high frequency) and rTMS (low frequency) in people with Memory, Episodic, run by Prof. Dominique de Quervain, MD at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A pilot study, examining the effect of repeated transcranial magnetic brain stimulation (rTMS) on the formation of memories with negative valence. The investigators hypothesize that an effective rTMS protocol to reduce memory performance for adverse events can be found. Read more about this study

Who is it for?
Ages 18 to 30 yearsHealthy volunteers can take part
Conditions the study is for
Memory, Episodic
What is being tested?
rTMS (cTBS 50Hz experiment), rTMS (high frequency) and rTMS (low frequency)
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
105 participants
Where
1 siteSwitzerland
Study dates
6 Jun 2023to 31 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Male or female
  • Generally healthy
  • Normotensive (BP 90/60mmHg - 140/90mmHg)
  • BMI: 19 - 30 kg/m2
  • Age: 18 - 30 years
  • Fluent German-speaking

Who cannot join

  • Metal in the brain, skull or elsewhere in the body (e.g., splinters, fragments, clips, etc.)
  • Implanted neurostimulator (e.g., DBS, epidural/subdural, VNS)
  • Cardiac pacemaker or intracardiac lines
  • Medication infusion device
  • Nonremovable Piercings in the head area, pivot teeth (retainers are no exclusion criterion)
  • Tattoos (head area) less than 3 months old or older than 20 years
Show all 18Show fewer
  • Condition after neurosurgery
  • Hearing problems or tinnitus
  • Not able to sit still due to tremor, tics, itching
  • History of repeated syncope
  • Head trauma diagnosed as concussion or associated with loss of consciousness
  • diagnosis of epilepsy, or a convulsion or a seizure in the past of the participant or his/her close family
  • TMS in the past showing problems
  • Surgical procedures to spinal cord
  • Spinal or ventricular derivations
  • Alcohol or drug intake 48 hours before start of visits
  • Regular intake of any medication or CNS-active medication 48h before visit
  • rMT above the limits of rTMS device.

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • University of Basel, Division of Cognitive Neuroscience

    Basel, Canton of Basel-City, 4055

Other trials in Switzerland

About this study

Official title: A Pilot Study on the Influence of Temporo-occipital Transcranial Magnetic Brain Stimulation on Aversive Episodic Memory Performance

A pilot study, examining the effect of repeated transcranial magnetic brain stimulation (rTMS) on the formation of memories with negative valence. The investigators hypothesize that an effective rTMS protocol to reduce memory performance for adverse events can be found.

Being tested
rTMS (cTBS 50Hz experiment), rTMS (cTBS sham), rTMS (cTBS 50 Hz active control), rTMS (high frequency), rTMS (low frequency)
Keywords
memory, Transcranial magnetic brain stimulation, emotional valence
Medical subject headings
Recurrence

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • rTMS (cTBS 50Hz experiment)Device

    rTMS using cTBS protocol with the following characteristics:

    • Frequency: trains of 50 Hz (3 pulses) every 200ms (frequency of 5 Hz, in the range of theta band)
    • Intensity: 80% of resting motor threshold (rMT)
    • Location: consecutively on the left and right temporo-occipital cortex (MNI coordinates: left hemisphere: -50, -72, 4; right hemisphere:50, -66, 0)
    • Duration: 40 seconds for each hemisphere, 80 seconds in total.
    • Timing: Immediately before viewing pictures in pictorial memory task (off-line)
  • rTMS (cTBS sham)Device

    rTMS using cTBS protocol with the following characteristics:

    • Frequency: trains of 50 Hz (3 pulses) every 200ms (frequency of 5 Hz, in the range of theta band)
    • Intensity: 0%
    • Location: consecutively on the left and right temporo-occipital cortex (MNI coordinates: left hemisphere: -50, -72, 4; right hemisphere:50, -66, 0)
    • Duration: 40 seconds for each hemisphere, 80 seconds in total.
    • Timing: Immediately before viewing pictures in pictorial memory task (off-line)
  • rTMS (cTBS 50 Hz active control)Device

    rTMS using cTBS protocol with the following characteristics:

    • Frequency: trains of 50 Hz (3 pulses) every 200ms (frequency of 5 Hz, in the range of theta band)
    • Intensity: 80% of resting motor threshold (rMT)
    • Location: Right superior frontal cortex
    • Duration: 40 seconds for each hemisphere, 80 seconds in total.
    • Timing: Immediately before viewing pictures in pictorial memory task (off-line)
  • rTMS (high frequency)Device

    rTMS using high frequency protocol with the following characteristics:

    • Frequency: 20 Hz
    • Intensity: 120% of rMT for rMT < 54% \& 65% of MSO for rMT ≥ 54%
    • Location: temporo-occipital cortex of the dominant brain hemisphere
    • Duration: 20 minutes, continuously
    • Timing: During the pictorial memory task (on-line) 1 second stimulation and 14 seconds inter-train interval for 76 trains resulting in a total of 1520 pulses.
  • rTMS (low frequency)Device

    rTMS using Low frequency protocol with the following characteristics:

    • Frequency: 1 Hz
    • Intensity: 110% of rMT
    • Location: temporo-occipital cortex of dominant brain hemisphere (MNI left hemisphere: -50, -72, 4; right hemisphere:50, -66, 0)
    • Duration: 30 minutes, continuously
    • Timing: Starting 10 minutes before and continuing during the picture viewing and valence rating of the pictures of the memory task (on-line).
  • rTMS (high frequency sham)Device

    • Frequency: 20 Hz
    • Intensity: 10% of MSO
    • Location: temporo-occipital cortex of the dominant brain hemisphere
    • Duration: 20 minutes, continuously
    • Timing: During the pictorial memory task (on-line) 1 second stimulation and 14 seconds inter-train interval for 76 trains resulting in a total of 1520 pulses.
  • rTMS (high frequency active control)Device

    • Frequency: 20 Hz
    • Intensity: 120% of rMT for rMT < 54% \& 65% of MSO for rMT ≥ 54%
    • Location: right superior frontal cortex of the dominant brain hemisphere
    • Duration: 20 minutes, continuously
    • Timing: During the pictorial memory task (on-line) 1 second stimulation and 14 seconds inter-train interval for 76 trains resulting in a total of 1520 pulses.
  • rTMS (low frequency active control )Device

    • Frequency: 1 Hz
    • Intensity: 110% of rMT
    • Location: Right superior frontal cortex of the dominant brain hemisphere
    • Duration: 6 minutes
    • Timing: Starting 1 minutes before and continuing during the memory task (Online)
  • rTMS ( cTBS 30 Hz active control)Device

    • Bilateral continuous theta burst stimulation (cTBS) 30 Hz:
    • Frequency: trains of 30 Hz (3 pulses) every 167 ms (frequency of 6 Hz, in the range of theta band)
    • Intensity: 100% of resting motor threshold (rMT)
    • Location: consecutively on right superior frontal cortex
    • Duration: 33.3 seconds for each side
    • Timing: Immediately before pictorial memory task (off-line)
  • rTMS (cTBS 30 Hz)Device

    • Bilateral continuous theta burst stimulation (cTBS) 30 Hz:
    • Frequency: trains of 30 Hz (3 pulses) every 167 ms (frequency of 6 Hz, in the range of theta band)
    • Intensity: 100% of resting motor threshold (rMT)
    • Location: consecutively on left and right temporo-occipital cortex
    • Duration: 33.3 seconds for each side
    • Timing: Immediately before pictorial memory task (off-line)
Study groups in NCT05847933
Study groupRoleWhat they receive
cTBS 50 Hz experimentExperimentalActive brain stimulation on the temporo-occipital cortex using the cTBS 50 Hz protocol.
Receives: Device: rTMS (cTBS 50Hz experiment)
cTBS shamSham comparatorSham brain stimulation on the temporo-occipital cortex using the cTBS 50Hz protocol pattern
Receives: Device: rTMS (cTBS sham)
cTBS 50Hz active controlActive comparatorActive brain stimulation on the right superior frontal cortex using the cTBS 50 Hz protocol
Receives: Device: rTMS (cTBS 50 Hz active control)
High frequencyExperimentalActive brain stimulation on the temporo-occipital cortex using the 20Hz protocol
Receives: Device: rTMS (high frequency)
Low frequencyExperimentalActive brain stimulation on the temporo-occipital cortex using the 1Hz protocol
Receives: Device: rTMS (low frequency)
cTBS 30HzExperimentalActive brain stimulation on the temporo-occipital cortex using the cTBS 30 Hz protocol.
Receives: Device: rTMS (cTBS 30 Hz)
cTBS 30 Hz Active controlActive comparatorActive brain stimulation on the right superior frontal cortex using the cTBS 30 Hz protocol
Receives: Device: rTMS ( cTBS 30 Hz active control)
High frequency Active controlActive comparatorActive brain stimulation on the right superior frontal cortex using the 20 Hz online protocol
Receives: Device: rTMS (high frequency active control)
Low frequency Active controlActive comparatorActive brain stimulation on the right superior frontal cortex using the 1 Hz offline protocol
Receives: Device: rTMS (low frequency active control )
High frequency shamSham comparatorBrain stimulation on the dominant temporo-occipital cortex using 10% maximum system output (MSO) and 20 Hz online protocol.
Receives: Device: rTMS (high frequency sham)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. memory recall performance

    The difference between valence specific (negative, positive, and neutral) memory performance as assessed by a standard picture recall episodic memory task.

    Measured: On average 1 hour after intervention

Secondary outcomes (1)
  1. Working memory performance

    Working memory performance measured by n-back task

    Measured: On average 1 hour after intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 May 2023
  2. Study start6 Jun 2023
  3. Primary completion1 Apr 2025
  4. Study completion31 May 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Sequential
Masking
None (open label)
Enrolment
105 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05847933
Sponsor's protocol ID
2023-00392
Other IDs
2023
Acronym
SAME
Status last verified
Jul 2025
First submitted
14 Apr 2023
Last updated
29 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All IPD (de-identified) that underlie results in a publication will be shared upon reasonable request

Questions about this trial

What is this clinical trial studying?

A study testing rTMS (cTBS 50Hz experiment), rTMS (high frequency) and rTMS (low frequency) in people with Memory, Episodic, run by Prof. Dominique de Quervain, MD at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 18 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

memory recall performance (time frame: On average 1 hour after intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in